What you need to know about the AstraZeneca, Moderna and Pfizer vaccines
.
Personally, I'm looking to elbow my way into the front of the first line I can join, but I know from my students that there's a lot of hesitation out there. How many TWebbers are planning to get vaccinated as soon as it's available, how many want to wait for more testing, and how many don't think they need to vaccinate at all?
.
As an at-risk college professor, I'm really hoping to be in that first group.
.
In the third such announcement in as many weeks, AstraZeneca revealed Monday that its vaccine candidate, developed by Oxford University, is up to 90 percent effective in clinical trials. Pfizer and its German partner, BioNTech, and Moderna have each reported vaccines that are 95 percent effective in trials.
Personally, I'm looking to elbow my way into the front of the first line I can join, but I know from my students that there's a lot of hesitation out there. How many TWebbers are planning to get vaccinated as soon as it's available, how many want to wait for more testing, and how many don't think they need to vaccinate at all?
.
Next steps
Companies will apply to federal regulators for authorization to provide the vaccines more broadly.
FDA regulators will review the effectiveness, safety and manufacturing of each vaccine.
An FDA advisory committee will vote on whether to recommend that the agency greenlight each vaccine.
December:
The FDA may authorize one or more vaccines.
One or two days later:
A Centers for Disease Control and Prevention advisory committee will discuss prioritizing vaccines for high-risk groups.
End of 2020:
The government projects that Pfizer and Moderna will provide 40 million doses, enough for 20 million people, by the end of the year. AstraZeneca has said the first 4 million doses could be ready in December, and 40 million could be delivered in the first quarter of 2021.
Companies will apply to federal regulators for authorization to provide the vaccines more broadly.
FDA regulators will review the effectiveness, safety and manufacturing of each vaccine.
An FDA advisory committee will vote on whether to recommend that the agency greenlight each vaccine.
December:
The FDA may authorize one or more vaccines.
One or two days later:
A Centers for Disease Control and Prevention advisory committee will discuss prioritizing vaccines for high-risk groups.
End of 2020:
The government projects that Pfizer and Moderna will provide 40 million doses, enough for 20 million people, by the end of the year. AstraZeneca has said the first 4 million doses could be ready in December, and 40 million could be delivered in the first quarter of 2021.
As an at-risk college professor, I'm really hoping to be in that first group.
Comment